palivizumab 100 MG per 1 ML Injection

RxCUI
1657341
RxNorm name
palivizumab 100 MG per 1 ML Injection
Display name
palivizumab 100 MG per 1 ML Injection
Full name
palivizumab 100 MG per 1 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103770Synagispalivizumab351(a)Disc2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3a0096c7-8139-44cd-bba4-520ab05c2cb2palivizumab 100 MG in 1 ML Injection [PSN] · 1 ML palivizumab 100 MG/ML Injection [SCD] · palivizumab 100 MG per 1 ML Injection [SY]38These highlights do not include all the information needed to use SYNAGIS safely and effectively. See full prescribing information for SYNAGIS. SYNAGIS ® (palivizumab) injection, for intramuscular use Initial U.S. Approval: 199820260121